Bladder Cancer
Conditions
Interventions
intervention group:Jindan With Extension Granules, Specification: 15g/bag, provided by Jiangxi Huatai Pharmaceutical Co. Usage: administered after exhaustion, boiled water for 12 days. Routine dosage:
Control group:None
Sponsors
Second Hospital of Tianjin Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 100 Years
Inclusion criteria
Inclusion criteria: 1. Men or women aged 18 years and above; 2. patients after radical total cystectomy with lymphatic clearance 3. expected survival time is large 4. subjects voluntarily enrolled in the study, signed the informed consent, complied well and cooperate with follow-up visits.
Exclusion criteria
Exclusion criteria: 1. Hypersensitivity to the components of the drugs used in this test; 2.Combined with liver, kidney (alanine aminotransferase, glutamic oxal transaminase =1.5 times the upper limit of normal value, blood creatinine exceeds the upper limit of normal value) and hematopoietic system and other serious primary (alanine transaminase, glutamic transaminase =1.5 times the upper limit of normal value, blood creatinine exceeds the upper limit of normal value) and hematopoietic system and other serious primary Patients with severe primary diseases such as liver, kidney (alanine aminotransferase =5 times the upper limit of normal value, blood creatinine exceeding the upper limit of normal value, hematopoietic system, etc.) and psychiatric diseases; 3. Those who have been examined and confirmed to have symptoms caused by other diseases; 4. Patients who have undergone other treatments related to the disease within two weeks; 5. Patients with severe coagulation disorders; 6. patients who are participating in other clinical trials; 7. patients with suspected or confirmed history of alcohol or drug abuse; 8.Those who, in the opinion of the investigator, are unsuitable for enrollment in this trial for other reasons.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| volume of drainage; | — |
Secondary
| Measure | Time frame |
|---|---|
| Quality of life score; | — |
Countries
China
Contacts
Public ContactHu Hailong
Second Hospital of Tianjin Medical Univertsity
Outcome results
None listed